Opens in a new tab

Global Health ROI Software & Analytics Platform

Global Health ROI Software & Analytics Platform
Listing ID
L#20250908
Target Price
€1,350,000
Revenue
TBD
EBITDA
TBA

Description

A market-proven health and wellness ROI software platform is available for acquisition or merger via an asset deal. This globally deployed Outcomes Management and ROI analytics and strategic planning solution is used by employers (both multinational and local), pharmaceutical companies, benefit consultants, healthcare payors, and wellness providers to measure outcomes and the return on investment (ROI) of intervention programs across physical, behavioral, and occupational health domains.

With proprietary software IP, global distribution relationships, and a curated database of country-specific productivity loss models, this asset is ideally positioned for integration into existing digital health, EAP, benefits consulting,HEOR/ Pharma or analytics businesses.

Asset Sale Includes

  • ROI© software platform (source code, models, calculators)
  • Global rights and trademarks
  • Proprietary data sets (productivity, cost, disease prevalence by country)
  • Client-facing training materials and user documentation
  • Distribution Network
  • Brand equity and promotional assets (multi-language website, articles, journal features)

Platform Strengths

  • Proven across 30+ countries including the U.S., Australia, South Africa,Canada, all European Countries, India, Mexico and Brazil.
  • Covers 25+ physical, behavioral, and infectious disease modules
  • Highly scalable model with low marginal costs and high-margin software licensing
  • Differentiated methodology developed with a leading global forecasting firm
  • Enables calculation of ROI, NPV, IRR, and breakeven points for employer-sponsored programs

Services

  • Licensing
  • Consulting
  • Training Courses
  • Support & Client Training

Promotion

  • Press/ LinkedIn Releases
  • Presentations and ROI training programs at conferences.
  • Articles in Journals
  • Web Site in different languages and Effective Call to Actions
  • Testimonials
  • Webinars
  • Word of Mouth

Future Development Plans:

  • Addition of New Countries
  • Addition of New Diseases and Conditions
  • Focus on Measuring Outcomes that are then converted to ROI

Basic Details

Listing ID
L#20250908
Country
United States
Industry
SAAS & Software
Deal Status
Available
Target Price
€1,350,000
Revenue
TBD
EBITDA
TBA
Revenue Multiple
TBD
EBITDA Multiple
TBD

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities